10.29.25 -- Outsourcing: You Own It, They Earn It

This digital event features industry experts who will share best practices for streamlining processes between sponsors and CDMOs. Register today for free and you can walk away with actionable insights into aligning analytical methods and quality standards to accelerate small molecule production and reduce risk across the development lifecycle.

In this session, Chief Scientific Officer Dr. Andy Lewis delves into the key drivers shaping peptide drug development and explores innovative delivery options to enhance therapeutic outcomes.

Discover the formulation process for preclinical testing by exploring pre-formulation studies, biopharm assessments, manufacturing, QC, regulatory aspects, and risk management — including a case study.

Mani Sundararajan, a former VP Tech Ops and Global Outsourcing executive at BMS, AstraZeneca, Shire and others, teaches us that despite the program or distance between you and your CDMOs, the key to success is to simplify outsourcing to the extent possible.

Experts explore permeation enhancers for drug absorption, PBPK modeling for formulation design, and fast-dissolving orally disintegrating tablets (ODTs) shaping drug development.

Reconstituted nasal epithelium (RNE) offers a human-relevant model for nasal drug delivery, outperforming frozen mucosa and aligning better with clinical outcomes for opioid formulations.

The simultaneous spray drying of multiple ingredients is a powerful technique for making inhaled products with multiple actives. Examine how novel techniques can make these products a reality.

It’s time to modernize your manufacturing operations – from digital work instructions and production records (EBR/eDHR) to electronic logbooks and equipment tracking.

We specialize in formulation development, clinical and commercial manufacturing, and packaging of complex oral solid dose, liquid, semi-solid, and sterile injectable products.

Can your product be NanoImproved? At a glance, check out our offerings for new molecules and reformulations, small molecules and biologics, technology details, and proof points.